Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA add-on to ethinylestradiol + levonorgestrel oral contraception for distressing decreased sexual desire
2020-000716-30Phase 2Completed
- Sponsor
- Gedeon Richter Plc
- Start
- Jul 2020
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypoactive sexual desire disorder (HSDD) comparing Ethinylestradiol + levonorgestrel + prasterone with Ethinylestradiol + levonorgestrel + placebo (2 arms). Primary endpoint: PFSF Desire Domain, change from baseline. Started Jul 2020; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on 2020-000716-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000716-30.